DarioHealth Statistics
Total Valuation
DarioHealth has a market cap or net worth of $34.15 million. The enterprise value is $26.61 million.
| Market Cap | 34.15M |
| Enterprise Value | 26.61M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, before market open.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
DarioHealth has 29.44 million shares outstanding. The number of shares has increased by 20.04% in one year.
| Shares Outstanding | 29.44M |
| Shares Change (YoY) | +20.04% |
| Shares Change (QoQ) | +0.30% |
| Owned by Insiders (%) | 14.81% |
| Owned by Institutions (%) | 29.43% |
| Float | 23.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.68 |
| Forward PS | 0.90 |
| PB Ratio | 0.59 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.79, with a Debt / Equity ratio of 0.51.
| Current Ratio | 3.79 |
| Quick Ratio | 3.38 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -91.80% and return on invested capital (ROIC) is -64.08%.
| Return on Equity (ROE) | -91.80% |
| Return on Assets (ROA) | -59.30% |
| Return on Capital (ROIC) | -64.08% |
| Revenue Per Employee | $73,739 |
| Profits Per Employee | -$230,112 |
| Employee Count | 276 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 2.21 |
Taxes
In the past 12 months, DarioHealth has paid $64,000 in taxes.
| Income Tax | 64,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.69% in the last 52 weeks. The beta is 1.66, so DarioHealth's price volatility has been higher than the market average.
| Beta (1Y) | 1.66 |
| 52-Week Price Change | -67.69% |
| 50-Day Moving Average | 1.67 |
| 200-Day Moving Average | 2.26 |
| Relative Strength Index (RSI) | 36.82 |
| Average Volume (30 Days) | 130,224 |
Short Selling Information
The latest short interest is 1.36 million, so 4.63% of the outstanding shares have been sold short.
| Short Interest | 1.36M |
| Short Previous Month | 1.34M |
| Short % of Shares Out | 4.63% |
| Short % of Float | 5.69% |
| Short Ratio (days to cover) | 11.53 |
Income Statement
In the last 12 months, DarioHealth had revenue of $20.35 million and -$63.51 million in losses. Loss per share was -$1.93.
| Revenue | 20.35M |
| Gross Profit | 5.98M |
| Operating Income | -56.19M |
| Pretax Income | -59.36M |
| Net Income | -63.51M |
| EBITDA | -54.38M |
| EBIT | -59.36M |
| Loss Per Share | -$1.93 |
Balance Sheet
The company has $37.09 million in cash and $29.54 million in debt, giving a net cash position of $7.55 million or $0.26 per share.
| Cash & Cash Equivalents | 37.09M |
| Total Debt | 29.54M |
| Net Cash | 7.55M |
| Net Cash Per Share | $0.26 |
| Equity / Book Value | 58.14M |
| Book Value Per Share | 1.97 |
| Working Capital | 34.84M |
Cash Flow
In the last 12 months, operating cash flow was -$30.38 million and capital expenditures -$584,000, giving a free cash flow of -$30.96 million.
| Operating Cash Flow | -30.38M |
| Capital Expenditures | -584,000 |
| Free Cash Flow | -30.96M |
| FCF Per Share | -$1.09 |
Margins
Gross margin is 29.40%, with operating and profit margins of -276.09% and -312.06%.
| Gross Margin | 29.40% |
| Operating Margin | -276.09% |
| Pretax Margin | -291.68% |
| Profit Margin | -312.06% |
| EBITDA Margin | -267.19% |
| EBIT Margin | -291.68% |
| FCF Margin | -152.14% |
Dividends & Yields
DarioHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.04% |
| Shareholder Yield | -20.04% |
| Earnings Yield | -185.96% |
| FCF Yield | -90.66% |
Analyst Forecast
The average price target for DarioHealth is $5.37, which is 362.93% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.37 |
| Price Target Difference | 362.93% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 55.86% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 18, 2019. It was a reverse split with a ratio of 1:20.
| Last Split Date | Nov 18, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
DarioHealth has an Altman Z-Score of -5.93 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.93 |
| Piotroski F-Score | 2 |